Free Trial
→ DOGE Social Security bombshell? (From Altimetry) (Ad) Buy CTOR Stock  Free CTOR Stock Alerts

Citius Oncology (CTOR) SEC Filings & 10K Form

Citius Oncology logo
$0.79 +0.08 (+11.83%)
Closing price 04:00 PM Eastern
Extended Trading
$0.80 +0.01 (+1.13%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Citius Oncology SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
3:45 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
8:22 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K/A
01/07/2025
8:10 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/16/2024
4:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mayersohn Joel David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:08 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:08 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SC 13G/A
09/13/2024
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:23 AM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
WOLVERINE ASSET MANAGEMENT LLC (Filed by)
Form SC 13G/A
08/30/2024
3:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4/A
08/16/2024
4:25 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:34 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Citius Pharmaceuticals, Inc. (Filed by)
Form SC 13D
08/15/2024
11:53 AM		10XYZ Holdings LP (Filed by)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Form SC 13D/A
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:20 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:20 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:21 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:22 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:23 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:23 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:24 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:24 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:25 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:26 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:26 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:27 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:28 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:28 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
DOGE officially begins retirement transformation (Ad)

Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retirement" process . This fired the starting gun on the biggest economic transformation in American history.

Here's everything you need to do BEFORE Elon has the chance to make his biggest move yet.
08/14/2024
5:29 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:33 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
08/09/2024
3:22 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
7:45 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
2:39 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
2:40 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
07/14/2024
11:15 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form EFFECT
07/12/2024
4:20 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 424B3
07/11/2024
2:50 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
07/11/2024
5:16 AM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
06/18/2024
12:35 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
12:36 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
06/17/2024
4:30 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
06/06/2024
4:28 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
4:29 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
05/21/2024
2:07 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
4:27 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
3:24 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form NT 10-Q
04/29/2024
3:45 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:46 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
04/16/2024
4:00 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/02/2024
10:08 AM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form NT 10-K
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CTOR) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners
A brutally honest economic warning for 2025 (see proof)
New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...
Behind the Markets | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored
Urgent Bitcoin alert for RIGHT NOW
Former billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...
Brownstone Research | Sponsored
Just Revealed: The chip company making AI look primitive
In his just-released video presentation, this renowned market strategist — who's been called "one of the most ...
InvestorPlace | Sponsored